Development of New Technologies Needed for Studying the Human Microbiome (R01)

The summary for the Development of New Technologies Needed for Studying the Human Microbiome (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of New Technologies Needed for Studying the Human Microbiome (R01): -Purpose. The purpose of this FOA is to solicit applications to develop new and improved technologies for obtaining samples of individual microbial isolates or strains, from the human microbiota, suitable for complete genomic sequence analysis. The goal is to expand the number of reference microbial genome sequences, which in turn will aid in the analysis of the complex microbial populations resident in and on the human body. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) grant mechanism and runs in parallel with a FOA of identical scientific scope, RFA RM-08-027 that solicits applications under the R21 mechanism -Funds Available and Anticipated Number of Awards. $2 million is available in FY09 for this FOA and the parallel R21 FOA in combination. It is anticipated that 2-4 R01 grants (of duration up to 3 years) and 2-6 R21 grants will be awarded, and that budgets will be negotiated to optimize the number of awards that can be made. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications
Federal Grant Title: Development of New Technologies Needed for Studying the Human Microbiome (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-08-026
Type of Funding: Grant
CFDA Numbers: 93.310
CFDA Descriptions: Trans-NIH Research Support
Current Application Deadline: No deadline provided
Original Application Deadline: Oct 02, 2008
Posted Date: Jul 15, 2008
Creation Date: Jul 15, 2008
Archive Date: Nov 02, 2008
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) .
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Large Animal Testing Centers for Evaluation of Somatic Cell Genome Editing Tools (U42 - Cl...
Collaborative Activities to Promote Cancer Cachexia Research (Admin Supp - Clinical Trial ...
NIH Directors Transformative Research Award (R01 - Clinical Trial Optional)
NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional)
NIH Director's Pioneer Award (DP1 - Clinical Trial Optional)
Using Metabolomics to Investigate Biological Pathways and Networks (R01)
Assay Development for High Throughput Molecular Screening (R21)
Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)
High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed)
High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer...
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp ...
Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial n...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com